Subramanian Loganathan

11PUBLICATIONS
1CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Optical technologyRheumatology and arthritisMedical biotechnology not elsewhere classifiedNanomedicine
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Jun 29, 2026
Safety and efficacy of biosimilar aflibercept MYL-1701P in diabetic macular oedema: 20-week extension results following the INSIGHT pivotal trial.

|May 08, 2026
Comparability of aflibercept biosimilar with reference aflibercept in diabetic macular edema: subgroup analysis of the pivotal Phase-III INSIGHT randomized clinical trial.

|Oct 16, 2025
Comparative efficacy and safety of biosimilar Bmab 1200 versus reference ustekinumab in moderate-to-severe plaque psoriasis: 52-week findings from the Phase 3 STELLAR-2 trial.

Jacek C Szepietowski, Adam Reich, Steven R Feldman

|Jul 25, 2025
Efficacy and safety of the ustekinumab biosimilar, Bmab 1200, versus reference ustekinumab in moderate-to-severe plaque psoriasis: 28‑week results of the randomized, double-blind, Phase 3 STELLAR-2 study.

Jacek C Szepietowski, Adam Reich, Steven R Feldman

|May 07, 2025
Pharmacokinetic equivalence and comparative safety, tolerability, and immunogenicity of Biocon's ustekinumab (Bmab-1200) with EU-approved and US-licensed reference ustekinumab in healthy subjects: results from the Study to Test pharmacokinetic BioEquivalence of BiosimiLar ustekinumab to SteLARa (STELLAR-1).

Jonathan Ackroyd, Sarika S Deodhar, Subramanian Loganathan

|Apr 11, 2025
An open-label, multiple ascending dose trial of orally administered insulin Tregopil in patients with type 1 diabetes mellitus to evaluate its pharmacokinetics, pharmacodynamics, safety and tolerability.

Esther Latres, Leona Plum-Moerschel, Sundara Moorthi Nainar Murugesan

Pageof 2

Frequent Collaborators

4 joint publications

Sarika S Deodhar